Acadian Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-465,247
| Closed | -$1.48M | – | 1942 |
|
|
2022
Q2 | $1.48M | Sell |
465,247
-12,441
| -3% | -$48.5K | 0.01% | 712 |
|
|
2022
Q1 | $2.04M | Buy |
477,688
+42,301
| +10% | +$184K | 0.01% | 660 |
|
|
2021
Q4 | $2.02M | Buy |
435,387
+67,219
| +18% | +$280K | 0.01% | 655 |
|
|
2021
Q3 | $1.47M | Buy |
368,168
+47,776
| +15% | +$190K | 0.01% | 753 |
|
|
2021
Q2 | $1.37M | Buy |
320,392
+205,446
| +179% | +$880K | 0.01% | 821 |
|
|
2021
Q1 | $487K | Buy |
+114,946
| New | +$633K | ﹤0.01% | 1208 |
|
|
2020
Q3 | – | Sell |
-278,664
| Closed | -$1.19M | – | 2486 |
|
|
2020
Q2 | $1.19M | Buy |
278,664
+250,215
| +880% | +$1.52M | 0.01% | 898 |
|
|
2020
Q1 | $120K | Sell |
28,449
-13,177
| -32% | -$83.2K | ﹤0.01% | 1315 |
|
|
2019
Q4 | $163K | Buy |
+41,626
| New | +$246K | ﹤0.01% | 1335 |
|
|
2015
Q4 | – | Sell |
-639
| Closed | -$18K | – | 1626 |
|
|
2015
Q3 | $18K | Sell |
639
-241
| -27% | -$7.59K | ﹤0.01% | 1067 |
|
|
2015
Q2 | $22K | Buy |
+880
| New | +$18.1K | ﹤0.01% | 1087 |
|
Acadian Asset Management's LJPC Position: Q3 2022 in Review
Acadian Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 465,247 shares — an estimated $1.48M sold.
Acadian Asset Management first reported a position in LJPC in Q2 2015 and held it in 11 quarters. The position peaked at $2.04M in Q1 2022. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- Acadian Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- Acadian Asset Management sold 465,247 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $1.48M.
- Acadian Asset Management first reported a position in La Jolla Pharmaceutical Company in Q2 2015 and held it in 11 quarters.
- Acadian Asset Management's La Jolla Pharmaceutical Company position peaked at $2.04M in Q1 2022.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on Acadian Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.